Stephen Ray Mitchell

Board Director

Director

Insider activity · 24 months0 buys2 salesCumulative net flow

Nov 24 · 0 buys · 1 saleDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 1 saleJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (4 ops.)

€113k

Latest filing published 16 Jun 2025 for Vanda Pharmaceuticals Inc., €28k. Read the official filing

Filing timeline

BuySale

Stephen Ray Mitchell

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Stephen Ray Mitchell: trading record in brief

This profile gathers the share dealings of Stephen Ray Mitchell in Vanda Pharmaceuticals Inc., where the filings describe the role as board member. The record holds 11 filings, for trades running from 10 June 2021 to 13 June 2025.

Every open-market trade on record is a sale: 4 sales worth €113k. Outside the open market, there are 5 share grants and 2 option exercises. Since January 2025: no purchases and 1 sale on the market.

The latest filing, published on 16 June 2025, reports an open-market sale of €28k in Vanda Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.